BIOSYENT INC. (RX.V) Financials
RX.V Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 41.5 million | 6.8 million |
| 2023-09-30 | 41.4 million | 6.8 million |
| 2023-06-30 | 39.5 million | 6.4 million |
| 2023-03-31 | 38.7 million | 5.3 million |
RX.V Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | 622647 | 136634 |
| 2023-09-30 | 2.4 million | 134161 |
| 2023-06-30 | 3.1 million | 124677 |
| 2023-03-31 | -1.2 million | 118014 |
RX.V Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | 1.5 million |
| 2023-09-30 | 2.4 million |
| 2023-06-30 | 1.5 million |
| 2023-03-31 | 1.2 million |
RX.V Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | - | - | 1.2 million |
| 2023-09-30 | - | - | 1.3 million |
| 2023-06-30 | - | - | 1.3 million |
| 2023-03-31 | - | - | 1.4 million |
RX.V Shares Outstanding
RX.V Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 52345 | 41543 | 4.9 million | - |
| 2023-09-30 | 18078 | 20128 | 4.2 million | - |
| 2023-06-30 | 3836 | 37377 | 4.5 million | - |
| 2023-03-31 | 3836 | 37665 | 3.7 million | - |
RX.V Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 8.3 million | 1.6 million |
| 2023-09-30 | 8.9 million | 1.8 million |
| 2023-06-30 | 8.0 million | 1.5 million |
| 2023-03-31 | 6.5 million | 1.1 million |
RX.V
Price: CA$8.24
Dividend Yield: 0.02%
Forward Dividend Yield: 2.15%
Payout Ratio: 33.96%
Dividend Per Share: 0.18 CAD
Earnings Per Share: 0.53 CAD
P/E Ratio: 16.71
Exchange: VAN
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 98.6 million
Average Dividend Frequency: 4
Years Paying Dividends: 3